Literature DB >> 9697805

Splenic rupture and abscess after extracorporeal shock wave lithotripsy.

O E Fugita1, F Trigo-Rocha, A I Mitre, S Arap.   

Abstract

Extracorporeal shock wave lithotripsy (ESWL) is the first choice for the treatment of most urinary stones. Complications of ESWL can be separated into two groups: those related to the administration of the shock waves and those related to fragmentation and elimination of the stone's particles. We report a rare case of splenic trauma followed by abscess after ESWL.

Entities:  

Mesh:

Year:  1998        PMID: 9697805     DOI: 10.1016/s0090-4295(98)00193-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

Review 1.  The acute and long-term adverse effects of shock wave lithotripsy.

Authors:  James A McAteer; Andrew P Evan
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

2.  Variables influencing the likelihood of cardiac dysrhythmias during extracorporeal shock wave lithotripsy.

Authors:  Thomas A A Skinner; Richard W Norman
Journal:  Can Urol Assoc J       Date:  2011-07-04       Impact factor: 1.862

3.  Perforation of the upper ureter: a rare complication of extracorporeal shock wave lithotripsy.

Authors:  Mehmet Turgut; Cavit Can; Aydin Yenilmez; Nevbahar Akcar
Journal:  Urol Res       Date:  2007-05-31

4.  Spleen injury following left extracorporeal shockwave lithotripsy (ESWL).

Authors:  Serge P Marinkovic; Christina M Marinkovic; Donghua Xie
Journal:  BMC Urol       Date:  2015-02-18       Impact factor: 2.264

Review 5.  [Ureteral stricture after extracorporeal shock wave lithotripsy. Case report and overview of the spectrum of rare side effects of modern ESWL treatment].

Authors:  F Finter; L Rinnab; J Simon; B Volkmer; R Hautmann; R Kuefer
Journal:  Urologe A       Date:  2007-07       Impact factor: 0.803

Review 6.  Long-term effects of pediatric extracorporeal shockwave lithotripsy on renal function.

Authors:  Yigit Akin; Selcuk Yucel
Journal:  Res Rep Urol       Date:  2014-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.